Analystreport

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $37.00 price target on the s

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com